Clinical Trial Update: HAIC Combined Withzoledronic Acid for the Prevention of Bone Metastases in Advanced HCC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with zoledronic acid to prevent bone metastases in advanced hepatocellular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HAIC (hepatic artery infusion chemotherapy)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN